scholarly article | Q13442814 |
P50 | author | Steven R Goldring | Q114399448 |
Adele L. Boskey | Q42152178 | ||
P2093 | author name string | Mone Zaidi | |
Bruce N Cronstein | |||
Bertil B Fredholm | |||
Stephen B Doty | |||
Firas M Kara | |||
P2860 | cites work | Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 |
RANK is essential for osteoclast and lymph node development | Q24598872 | ||
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL | Q24682139 | ||
Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee | Q29616160 | ||
Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor | Q33931315 | ||
Marrow stromal stem cells | Q33947769 | ||
Calcineurin regulates bone formation by the osteoblast | Q34144729 | ||
Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis | Q35546429 | ||
Cells of the synovium in rheumatoid arthritis. Osteoclasts | Q35769060 | ||
Pathological role of osteoclast costimulation in arthritis-induced bone loss. | Q36090203 | ||
Molecular modeling of adenosine receptors: new results and trends. | Q36816987 | ||
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism | Q37108966 | ||
Epidemiology of osteoporosis and osteoporotic fractures | Q39832253 | ||
Bifurcation of osteoclasts and dendritic cells from common progenitors | Q43757343 | ||
Homocysteine levels in patients with rheumatoid arthritis treated with low-dose methotrexate | Q44340870 | ||
The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene | Q59092154 | ||
Coffee, tea and caffeine consumption in relation to osteoporotic fracture risk in a cohort of Swedish women | Q59806015 | ||
Anti-arthritic effect of methotrexate: is it really mediated by adenosine? | Q73422815 | ||
Quantification of Bone Microarchitecture with the Structure Model Index | Q73663325 | ||
Could apoptosis be responsible for localized imbalances in bone cell homeostasis? | Q78245657 | ||
P433 | issue | 2 | |
P921 | main subject | knockout mouse | Q1364740 |
P304 | page(s) | 534-541 | |
P577 | publication date | 2010-02-01 | |
P1433 | published in | Arthritis & Rheumatology | Q4797636 |
P1476 | title | Adenosine A(1) receptors regulate bone resorption in mice: adenosine A(1) receptor blockade or deletion increases bone density and prevents ovariectomy-induced bone loss in adenosine A(1) receptor-knockout mice | |
P478 | volume | 62 |
Q35106323 | Aberrant bone density in aging mice lacking the adenosine transporter ENT1. |
Q37318889 | Activation of adenosine A(2A) receptor reduces osteoclast formation via PKA- and ERK1/2-mediated suppression of NFκB nuclear translocation |
Q35951939 | Adenosine A(2A) receptor ligation inhibits osteoclast formation. |
Q35953968 | Adenosine A1 receptor regulates osteoclast formation by altering TRAF6/TAK1 signaling. |
Q33919462 | Adenosine A1 receptors (A1Rs) play a critical role in osteoclast formation and function. |
Q36067491 | Adenosine A2A receptor activation prevents wear particle-induced osteolysis |
Q41453417 | Adenosine Receptor Stimulation Improves Glucocorticoid-Induced Osteoporosis in a Rat Model |
Q39158939 | Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields |
Q50115228 | Adenosine abolishes MTX-induced suppression of osteoclastogenesis and inflammatory bone destruction in adjuvant-induced arthritis |
Q34036039 | Adenosine and bone metabolism |
Q45609994 | Adenosine blocks aminopterin-induced suppression of osteoclast differentiation |
Q37948081 | Adenosine receptor targeting in health and disease |
Q29346491 | Adenosine receptors as drug targets--what are the challenges? |
Q37118787 | Adenosine regulates bone metabolism via A1, A2A, and A2B receptors in bone marrow cells from normal humans and patients with multiple myeloma. |
Q37850997 | Advances in osteoclast biology: old findings and new insights from mouse models |
Q55062269 | Age-dependent variations of cancellous bone in response to ovariectomy in C57BL/6J mice. |
Q21131280 | An emerging role for adenosine and its receptors in bone homeostasis |
Q64944461 | Bone Marrow Adipose Tissue and Skeletal Health. |
Q35840782 | Bone destruction by receptor activator of nuclear factor κB ligand-expressing T cells in chronic gouty arthritis |
Q35612746 | CD73-generated adenosine promotes osteoblast differentiation |
Q47133411 | Caffeine at a Moderate Dose Did Not Affect the Skeletal System of Rats with Streptozotocin-Induced Diabetes |
Q91598371 | Dipyridamole Augments Three-Dimensionally Printed Bioactive Ceramic Scaffolds to Regenerate Craniofacial Bone |
Q35410561 | Direct or indirect stimulation of adenosine A2A receptors enhances bone regeneration as well as bone morphogenetic protein-2. |
Q42035054 | Does adenosine play a role in bone formation, resorption and repair? |
Q92924705 | Dysregulation of ectonucleotidase-mediated extracellular adenosine during postmenopausal bone loss |
Q38664528 | Effects of pulsed electromagnetic fields on postmenopausal osteoporosis |
Q33705612 | Endogenous adenosine maintains cartilage homeostasis and exogenous adenosine inhibits osteoarthritis progression. |
Q44933307 | Favorable effect of moderate dose caffeine on the skeletal system in ovariectomized rats. |
Q34701303 | International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update |
Q40932223 | Lack of effect of adenosine on the function of rodent osteoblasts and osteoclasts in vitro. |
Q64235092 | Mechanisms of Osteoblastic Bone Metastasis in Prostate Cancer: Role of Prostatic Acid Phosphatase |
Q34761392 | Pulsed electromagnetic fields increased the anti-inflammatory effect of A₂A and A₃ adenosine receptors in human T/C-28a2 chondrocytes and hFOB 1.19 osteoblasts |
Q37468714 | Purinergic signalling in the musculoskeletal system. |
Q37442054 | Regulation of bone and cartilage by adenosine signaling. |
Q36746981 | Regulation of inflammation by adenosine. |
Q36070200 | Regulation of macrophage function by adenosine |
Q37337859 | Rolofylline, an adenosine A1 receptor antagonist, inhibits osteoclast differentiation as an inverse agonist |
Q89619982 | Signaling of the Purinergic System in the Joint |
Q92990019 | The Adenosine A2B Receptor Drives Osteoclast-Mediated Bone Resorption in Hypoxic Microenvironments |
Q47109047 | The Inactivation of ERK1/2, p38 and NF-kB Is Involved in the Down-Regulation of Osteoclastogenesis and Function by A2B Adenosine Receptor Stimulation |
Q56262600 | The role of 3D printing in treating craniomaxillofacial congenital anomalies |
Q90913018 | The role of GPCRs in bone diseases and dysfunctions |
Q26768507 | The role of purinergic receptors in stem cell differentiation |
Search more.